» Articles » PMID: 38694941

Mechanisms of Mitochondrial Dysfunction in Ovarian Aging and Potential Interventions

Overview
Specialty Endocrinology
Date 2024 May 2
PMID 38694941
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondria plays an essential role in regulating cellular metabolic homeostasis, proliferation/differentiation, and cell death. Mitochondrial dysfunction is implicated in many age-related pathologies. Evidence supports that the dysfunction of mitochondria and the decline of mitochondrial DNA copy number negatively affect ovarian aging. However, the mechanism of ovarian aging is still unclear. Treatment methods, including antioxidant applications, mitochondrial transplantation, emerging biomaterials, and advanced technologies, are being used to improve mitochondrial function and restore oocyte quality. This article reviews key evidence and research updates on mitochondrial damage in the pathogenesis of ovarian aging, emphasizing that mitochondrial damage may accelerate and lead to cellular senescence and ovarian aging, as well as exploring potential methods for using mitochondrial mechanisms to slow down aging and improve oocyte quality.

Citing Articles

Comparative Transcriptomic Analysis Reveals New Insights into Spawn Aging in : Mitochondrial Dysfunction.

Shu L, Zeng Z, Chen M, Zhao J, Zhang X, Dai J Int J Mol Sci. 2025; 26(2.

PMID: 39859563 PMC: 11766156. DOI: 10.3390/ijms26020849.


Nicotinamide mononucleotide boosts the development of bovine oocyte by enhancing mitochondrial function and reducing chromosome lagging.

Hashimoto S, Gamage U, Inoue Y, Iwata H, Morimoto Y Sci Rep. 2025; 15(1):310.

PMID: 39747142 PMC: 11696260. DOI: 10.1038/s41598-024-81393-z.


Canagliflozin treatment prevents follicular exhaustion and attenuates hallmarks of ovarian aging in genetically heterogenous mice.

Isola J, Biswas S, Jayarathne H, Hubbart C, Hense J, Matsuzaki S Geroscience. 2024; .

PMID: 39672978 DOI: 10.1007/s11357-024-01465-w.


Exploring the innovative application of cerium oxide nanoparticles for addressing oxidative stress in ovarian tissue regeneration.

Lakshmanan M, Saini M, Nune M J Ovarian Res. 2024; 17(1):241.

PMID: 39633503 PMC: 11619646. DOI: 10.1186/s13048-024-01566-2.


Mitochondria: the epigenetic regulators of ovarian aging and longevity.

Mani S, Srivastava V, Shandilya C, Kaushik A, Singh K Front Endocrinol (Lausanne). 2024; 15:1424826.

PMID: 39605943 PMC: 11598335. DOI: 10.3389/fendo.2024.1424826.


References
1.
Pasquariello R, Ermisch A, Silva E, McCormick S, Logsdon D, Barfield J . Alterations in oocyte mitochondrial number and function are related to spindle defects and occur with maternal aging in mice and humans†. Biol Reprod. 2018; 100(4):971-981. DOI: 10.1093/biolre/ioy248. View

2.
Al-Shaikh G, Ibrahim G, Fayed A, Al-Mandeel H . Grand multiparity and the possible risk of adverse maternal and neonatal outcomes: a dilemma to be deciphered. BMC Pregnancy Childbirth. 2017; 17(1):310. PMC: 5606064. DOI: 10.1186/s12884-017-1508-0. View

3.
Shi W, Xu B, Wu L, Jin R, Luan H, Luo L . Oocytes with a dark zona pellucida demonstrate lower fertilization, implantation and clinical pregnancy rates in IVF/ICSI cycles. PLoS One. 2014; 9(2):e89409. PMC: 3933533. DOI: 10.1371/journal.pone.0089409. View

4.
Pahlavani H, Laher I, Knechtle B, Zouhal H . Exercise and mitochondrial mechanisms in patients with sarcopenia. Front Physiol. 2022; 13:1040381. PMC: 9767441. DOI: 10.3389/fphys.2022.1040381. View

5.
Ntostis P, Iles D, Kokkali G, Vaxevanoglou T, Kanavakis E, Pantou A . The impact of maternal age on gene expression during the GV to MII transition in euploid human oocytes. Hum Reprod. 2021; 37(1):80-92. PMC: 8730309. DOI: 10.1093/humrep/deab226. View